WHO ICTRP trial
Combination of dexmedetomidine and timing propofol inhibited the ED50/ED95 of…
ChiCTR2000039747 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000039747 |
|---|---|
| Public title | Combination of dexmedetomidine and timing propofol inhibited the ED50/ED95 of expanded uterine motor response in hysteroscopy patients |
| Scientific title | Combination of dexmedetomidine and timing propofol inhibited the ED50/ED95 of expanded uterine motor response in hysteroscopy patients |
| Primary sponsor | Ningbo Medical Center Li Huili Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Hysteroscopic intravenous anesthesia |
| Interventions | 1:Propofol 1.6 mg/kg;2:Propofol 1.8 mg/kg;3:Propofol 2.0 mg/kg;4:Propofol 2.2 mg/kg;5:Propofol 2.4 mg/kg;6:Propofol 2.6 mg/kg;7:Dexmedetomidine 0.5ug /kg propofol 1.0mg /kg;8:Dexmedetomidine 0.5ug /kg propofol 1.2mg /kg;9:Dexmedetomidine… |
| Registration date | Nov 7, 2020 |
| Target size | 1:10;2:10;3:10;4:10;5:10;6:10;7:10;8:10;9:10;10:10;11:10;12:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: